In conclusion, this study elucidates LASI lncRNA as a novel regulator of CSE-induced and COPD-associated airway epithelial dysregulation and further suggests that targeting LASI lncRNA expression could present a novel therapeutic intervention modality to treat COPD phenotypes of upper airways. This evidence concerns the gene LIMASI and chronic obstructive pulmonary disease.